arrow
M

Michael C. Leo

Kaiser Permanente Center for Health Research
H指数:37
被引数:5,798

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Factors associated with personal and professional beliefs about vaccines: a cross-sectional study of national dental practice-based research dentists

与疫苗的个人和专业信念相关的因素:一项针对全国牙科实践基础研究牙医的横断面研究

2026-08-310
OA
A National Dental Practice-Based Research Network phase II, cluster-randomized clinical trial assessing nicotine replacement therapy sampling in dental settings: study protocol for the Free Samples for Health (FreSH) study

一项基于全国牙科实践研究网络的第二阶段、整群随机临床试验,评估牙科环境中的尼古丁替代疗法样本:Free Samples for Health(FreSH)研究的研究方案

2026-04-050
OAAI
Limitations in the Application of Clinicopathologic Factors Alone in Predicting Radiation Benefit for Women with Low-Risk Ductal Carcinoma in Situ after Breast Conserving Surgery: The Impact of a 7-gene Biosignature based on 10-Year Ipsilateral Breast Recurrence (IBR) Rates

仅依靠临床病理因素预测行保乳术后低风险导管原位癌女性放疗获益的应用局限性:基于10年同侧乳腺复发(IBR)率的7基因生物标志物的影响

2025-07-180
PREAI
Genomic sequencing in diverse and underserved pediatric populations: Parent perspectives on understanding, uncertainty, psychosocial impact, and personal utility of results

在多样化和弱势儿童人群中的基因组测序:家长对结果的理解、不确定性、心理社会影响和个人效用观点

2025-04-010
PRE
A 7-Gene Biosignature for Ductal Carcinoma in situ of the Breast Identifies Subpopulations of HER2-positive Patients With Distinct Recurrence Rates After Breast-Conserving Surgery and Radiation Therapy

一种用于乳腺导管原位癌的7基因生物标志物,可识别在乳腺保乳手术和放射治疗后具有不同复发率的HER2阳性患者亚群

2025-02-010
OAAI
7-gene predictive biosignature improves risk stratification for breast ductal carcinoma in situ patients compared to clinicopathologic criteria, identifying a low risk group not clinically benefiting from adjuvant radiotherapy
2023-03-011
PRE
Characterization of recurrence risk after lumpectomy and radiotherapy in HER2-positive ductal carcinoma in situ of the breast, using 7-gene predictive biosignature: Implications for the NSABP-B43 trial results
2023-03-010
PRE